Cerapedics Inc. successfully treated the first U.S. patient using its newly approved bone graft designed to accelerate lumbar fusion. This marks a significant milestone following the approval from the U.S. Food and Drug Administration (FDA) for the PearlMatrix P-15 Peptide Enhanced Bone Graft. The procedure was carried out at AdventHealth Avista in Louisville, Colo., by…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here